Abstract
AbstractThe NF-κB family of transcription factors functions broadly in the host control of immunoregulatory gene expression, inflammation, and apoptosis. Using Jurkat T cells engineered to inducibly express a transdominant repressor of IκBα, we examined the role of NF-κB in the regulation of cytokine and apoptotic gene expression. In this T cell model, as well as in primary T lymphocytes, expression of TNF-related apoptosis-inducing ligand (TRAIL) apoptotic signaling protein was dramatically down-regulated by inhibition of NF-κB binding activity. TRAIL acts through membrane death receptors to induce apoptosis of activated T lymphocytes and can be up-regulated by a variety of physiological and pharmacological inducers. However, regulation of TRAIL gene expression has not been defined. Treatment with TCR mimetics (PMA/ionomycin, PHA, and anti-CD3/CD28 Abs) resulted in a rapid increase in the expression of TRAIL mRNA and cell surface TRAIL protein. Induction of the transdominant repressor of IκBα dramatically down-regulated surface expression of TRAIL, indicating an essential role for NF-κB in the regulation of TRAIL. The induced expression of TRAIL was linked to a c-Rel binding site in the proximal TRAIL promoter at position −256 to −265; mutation of this site or an adjacent κB site resulted in a complete loss of the inducibility of the TRAIL promoter. The regulation of TRAIL expression by NF-κB may represent a general mechanism that contributes to the control of TRAIL-mediated apoptosis in T lymphocytes.
References
70
Referenced
101
-
Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, et al 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673
(
10.1016/1074-7613(95)90057-8
) -
Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271: 12687
(
10.1074/jbc.271.22.12687
) -
Pan, G., K. O’Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111
(
10.1126/science.276.5309.111
) -
Pan, G., J. Ni, Y. F. Wei, G. Yu, R. Gentz, V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815
(
10.1126/science.277.5327.815
) -
Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818
(
10.1126/science.277.5327.818
) -
Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, R. G. Goodwin, C. T. Rauch. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16: 5386
(
10.1093/emboj/16.17.5386
) -
MacFarlane, M., M. Ahmad, S. M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272: 25417
(
10.1074/jbc.272.41.25417
) -
Keogh, S. A., H. Walczak, L. Bouchier-Hayes, S. J. Martin. 2000. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis. FEBS Lett. 471: 93
(
10.1016/S0014-5793(00)01375-2
) -
Schneider, P., M. Thome, K. Burns, J. L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7: 831
(
10.1016/S1074-7613(00)80401-X
) -
Kischkel, F. C., D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim, A. Ashkenazi. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611
(
10.1016/S1074-7613(00)80212-5
) -
Chaudhary, P. M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7: 821
(
10.1016/S1074-7613(00)80400-8
) -
Yeh, W. C., J. L. Pompa, M. E. McCurrach, H. B. Shu, A. J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, et al 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954
(
10.1126/science.279.5358.1954
) -
Hu, W. H., H. Johnson, H. B. Shu. 1999. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274: 30603
(
10.1074/jbc.274.43.30603
) -
Gura, T.. 1997. How TRAIL kills cancer cells, but not normal cells. Science 277: 768
(
10.1126/science.277.5327.768
) -
Viret, C., F. S. Wong, C. A. Janeway. 1999. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10: 559
(
10.1016/S1074-7613(00)80055-2
) -
Degli-Esposti, M. A., P. J. Smolak, H. Walczak, J. Waugh, C. P. Huang, R. F. DuBose, R. G. Goodwin, C. A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186: 1165
(
10.1084/jem.186.7.1165
) -
Degli-Esposti, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, R. G. Goodwin. 1997. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7: 813
(
10.1016/S1074-7613(00)80399-4
) -
Kayagaki, N., N. Yamaguchi, M. Nakayama, K. Takeda, H. Akiba, H. Tsutsui, H. Okamura, K. Nakanishi, K. Okumura, H. Yagita. 1999. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163: 1906
(
10.4049/jimmunol.163.4.1906
) -
Kayagaki, N., N. Yamaguchi, M. Nakayama, H. Eto, K. Okumura, H. Yagita. 1999. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189: 1451
(
10.1084/jem.189.9.1451
) -
Takeda, K., Y. Hayakawa, M. J. Smyth, N. Kayagaki, N. Yamaguchi, S. Kakuta, Y. Iwakura, H. Yagita, K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7: 94
(
10.1038/83416
) -
Jeremias, I., I. Herr, T. Boehler, K. M. Debatin. 1998. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28: 143
(
10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3
) -
Martinez-Lorenzo, M. J., M. A. Alava, S. Gamen, K. J. Kim, A. Chuntharapai, A. Pineiro, J. Naval, A. Anel. 1998. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28: 2714
(
10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9
) -
Martinez-Lorenzo, M. J., A. Anel, S. Gamen, I. Monle n, P. Lasierra, L. Larrad, A. Pineiro, M. A. Alava, J. Naval. 1999. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163: 1274
(
10.4049/jimmunol.163.3.1274
) -
Baeuerle, P. A.. 1998. IκB-NF-κB structures: at the interface of inflammation control. Cell 95: 729
(
10.1016/S0092-8674(00)81694-3
) -
Huxford, T., D.-B. Huang, S. Malek, G. Ghosh. 1998. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95: 759
(
10.1016/S0092-8674(00)81699-2
) -
Jacobs, M. D., S. C. Harrison. 1998. Structure of an IκBα/NF-κB complex. Cell 95: 749
(
10.1016/S0092-8674(00)81698-0
) -
Beauparlant, P., R. Lin, J. Hiscott. 1996. The role of the C-terminal domain of IκBα in protein degradation and stability. J. Biol. Chem. 271: 10690
(
10.1074/jbc.271.18.10690
) -
Brown, K., G. Franzoso, L. Baldi, L. Carlson, L. Mills, Y.-C. Lin, S. Gerstberger, U. Siebenlist. 1997. The signal response of IκBα is regulated by transferable N- and C-terminal domains. Mol. Cell. Biol. 17: 3021
(
10.1128/MCB.17.6.3021
) -
Ernst, M. K., L. L. Dunn, N. R. Rice. 1995. The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol. Cell. Biol. 15: 872
(
10.1128/MCB.15.2.872
) -
Jaffray, E., K. M. Wood, R. T. Hay. 1995. Domain organization of IκBα and the sites of interaction with NF-κB p65. Mol. Cell. Biol. 15: 2166
(
10.1128/MCB.15.4.2166
) -
Lin, R., P. Beauparlant, C. Makris, S. Meloche, J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16: 1401
(
10.1128/MCB.16.4.1401
) -
Rodriguez, M. S., I. Michalopoulos, F. Arenzana-Seisdedos, R. T. Hay. 1995. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol. Cell. Biol. 15: 2413
(
10.1128/MCB.15.5.2413
) -
DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548
(
10.1038/41493
) -
Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90: 373
(
10.1016/S0092-8674(00)80344-X
) -
Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243
(
10.1016/S0092-8674(00)80406-7
) -
Yaron, A., H. Gonen, I. Alkalay, A. Hatzubai, S. Jung, S. Beyth, F. Mercurio, A. M. Manning, A. Ciechanover, Y. Ben-Neriah. 1997. Inhibition of NF-κB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J. 21: 6486
(
10.1093/emboj/16.21.6486
) -
Yaron, A., A. Hatzubai, M. Davis, I. Lavon, S. Amit, A. M. Manning, J. S. Andersen, M. Mann, F. Mercurio, Y. Ben-Neriah. 1998. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396: 590
(
10.1038/25159
) -
Brown, K., S. Park, T. Kanno, G. Franzoso, U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90: 2532
(
10.1073/pnas.90.6.2532
) -
Chiao, P. J., S. Miyamoto, I. M. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91: 28
(
10.1073/pnas.91.1.28
) -
Sun, S.-C., P. A. Ganchi, D. W. Ballard, W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912
(
10.1126/science.8096091
) -
Scott, M. L., T. Fujita, H.-C. Liou, G. P. Nolan, D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7: 1266
(
10.1101/gad.7.7a.1266
) -
de Martin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, F. H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12: 2773
(
10.1002/j.1460-2075.1993.tb05938.x
) -
Le Bail, O., R. Schmidt-Ullrich, A. Israël. 1993. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12: 5043
(
10.1002/j.1460-2075.1993.tb06197.x
) -
Kwon, H., N. Pelletier, C. DeLuca, P. Genin, S. Cisternas, R. Lin, M. A. Wainberg, J. Hiscott. 1998. Inducible expression of IκBα repressor mutants interferes with NF-κB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273: 7431
(
10.1074/jbc.273.13.7431
) -
Algarte, M., H. Kwon, P. Genin, J. Hiscott. 1999. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-κB and Sp1 that regulates the IκBα promoter. Mol. Cell. Biol. 19: 6140
(
10.1128/MCB.19.9.6140
) -
Gossen, M., S. Freundlieb, G. Bender, G. Müller, W. Hillen, H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766
(
10.1126/science.7792603
) -
Yin, M. J., Y. Yamamoto, R. B. Gaynor. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396: 77
(
10.1038/23948
) -
Kopp, E., S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956
(
10.1126/science.8052854
) -
Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272: 21096
(
10.1074/jbc.272.34.21096
) -
Wang, Q., Y. Ji, X. Wang, B. M. Evers. 2000. Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene. Biochem. Biophys. Res. Commun. 276: 466
(
10.1006/bbrc.2000.3512
) -
Malinin, N. L., M. P. Boldin, A. V. Kovalenko, D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540
(
10.1038/385540a0
) -
Fanger, N. A., C. R. Maliszewski, K. Schooley, T. S. Griffith. 1999. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190: 1155
(
10.1084/jem.190.8.1155
) -
Kayagaki, N., N. Yamaguchi, M. Nakayama, A. Kawasaki, H. Akiba, K. Okumura, H. Yagita. 1999. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J. Immunol. 162: 2639
(
10.4049/jimmunol.162.5.2639
) -
Kaplan, M. J., D. Ray, R. R. Mo, R. L. Yung, B. C. Richardson. 2000. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J. Immunol. 164: 2897
(
10.4049/jimmunol.164.6.2897
) -
Barkett, M., T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18: 6910
(
10.1038/sj.onc.1203238
) -
Kasibhatla, S., L. Genestier, D. R. Green. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB. J. Biol. Chem. 274: 987
(
10.1074/jbc.274.2.987
) -
Matsui, K., A. Fine, B. Zhu, A. Marshak-Rothstein, S. T. Ju. 1998. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161: 3469
(
10.4049/jimmunol.161.7.3469
) -
Wang, J., M. J. Lenardo. 1997. Essential lymphocyte function associated 1 (LFA-1): intercellular adhesion molecule interactions for T cell-mediated B cell apoptosis by Fas/APO-1/CD95. J. Exp. Med. 186: 1171
(
10.1084/jem.186.7.1171
) -
Debatin, K. M., C. K. Goldman, T. A. Waldmann, P. H. Krammer. 1993. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81: 2972
(
10.1182/blood.V81.11.2972.bloodjournal81112972
) -
Walczak, H., R. E. Miller, K. Ariail, B. Gliniak, T. S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, et al 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5: 157
(
10.1038/5517
) -
Gruss, H. J., S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85: 3378
(
10.1182/blood.V85.12.3378.bloodjournal85123378
) -
Katsikis, P. D., M. E. Garcia-Ojeda, E. S. Wunderlich, C. A. Smith, H. Yagita, K. Okumura, N. Kayagaki, M. Alderson, L. A. Herzenberg. 1996. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int. Immunol. 8: 1311
(
10.1093/intimm/8.8.1311
) -
Katsikis, P. D., M. E. Garcia-Ojeda, J. F. Torres-Roca, I. M. Tijoe, C. A. Smith, L. A. Herzenberg. 1997. Interleukin-1β converting enzyme-like protease involvement in Fas- induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation- induced T cell death in HIV infection. J. Exp. Med. 186: 1365
(
10.1084/jem.186.8.1365
) -
Clarke, P., S. M. Meintzer, S. Gibson, C. Widmann, T. P. Garrington, G. L. Johnson, K. L. Tyler. 2000. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74: 8135
(
10.1128/JVI.74.17.8135-8139.2000
) -
Vidalain, P. O., O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-Combe, C. Servet-Delprat. 2000. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74: 556
(
10.1128/JVI.74.1.556-559.2000
) -
Sedger, L. M., D. M. Shows, R. A. Blanton, J. J. Peschon, R. G. Goodwin, D. Cosman, S. R. Wiley. 1999. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163: 920
(
10.4049/jimmunol.163.2.920
) -
McCaffrey, P. G., A. E. Goldfeld, A. Rao. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-α gene transcription. J. Biol. Chem. 269: 30445
(
10.1016/S0021-9258(18)43833-1
) -
Venkataraman, L., S. J. Burakoff, R. Sen. 1995. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181: 1091
(
10.1084/jem.181.3.1091
) -
Venkataraman, L., W. Wang, R. Sen. 1996. Differential regulation of c-Rel translocation in activated B and T cells. J. Immunol. 157: 1149
(
10.4049/jimmunol.157.3.1149
) -
Chow, W. A., J. J. Fang, J. K. Yee. 2000. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J. Immunol. 164: 3512
(
10.4049/jimmunol.164.7.3512
)
Dates
Type | When |
---|---|
Created | 11 years, 4 months ago (April 20, 2014, 7:30 p.m.) |
Deposited | 7 months, 3 weeks ago (Jan. 2, 2025, 1:56 p.m.) |
Indexed | 3 months, 1 week ago (May 18, 2025, 12:04 p.m.) |
Issued | 23 years, 11 months ago (Sept. 15, 2001) |
Published | 23 years, 11 months ago (Sept. 15, 2001) |
Published Print | 23 years, 11 months ago (Sept. 15, 2001) |
@article{Baetu_2001, title={Disruption of NF-κB Signaling Reveals a Novel Role for NF-κB in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression}, volume={167}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.167.6.3164}, DOI={10.4049/jimmunol.167.6.3164}, number={6}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Baetu, Tudor M. and Kwon, Hakju and Sharma, Sonia and Grandvaux, Nathalie and Hiscott, John}, year={2001}, month=sep, pages={3164–3173} }